These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12437079)

  • 21. Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc.
    Zalem D; Juhás M; Terrinoni M; King-Lyons N; Lebens M; Varrot A; Connell TD; Teneberg S
    Glycobiology; 2022 Apr; 32(5):391-403. PubMed ID: 34972864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
    Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
    Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.
    Kim TG; Kim BG; Kim MY; Choi JK; Jung ES; Yang MS
    Mol Biotechnol; 2010 Jan; 44(1):14-21. PubMed ID: 19657748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge.
    Rosales-Mendoza S; Soria-Guerra RE; López-Revilla R; Moreno-Fierros L; Alpuche-Solís AG
    Plant Cell Rep; 2008 Jan; 27(1):79-84. PubMed ID: 17874110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
    Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
    Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
    de Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
    Vaccine; 1996 Mar; 14(4):260-6. PubMed ID: 8744549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.
    Gilligan PH; Brown JC; Robertson DC
    Infect Immun; 1983 Nov; 42(2):683-91. PubMed ID: 6196292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.
    Tamura S; Yamanaka A; Shimohara M; Tomita T; Komase K; Tsuda Y; Suzuki Y; Nagamine T; Kawahara K; Danbara H
    Vaccine; 1994 Apr; 12(5):419-26. PubMed ID: 8023550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein.
    Wu CM; Chung TC
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):354-65. PubMed ID: 17651125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.
    Moravec T; Schmidt MA; Herman EM; Woodford-Thomas T
    Vaccine; 2007 Feb; 25(9):1647-57. PubMed ID: 17188785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.
    Clements JD; Hartzog NM; Lyon FL
    Vaccine; 1988 Jun; 6(3):269-77. PubMed ID: 3048010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin.
    Holmgren J; Fredman P; Lindblad M; Svennerholm AM; Svennerholm L
    Infect Immun; 1982 Nov; 38(2):424-33. PubMed ID: 7141703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
    Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
    Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
    Tamura SI; Kurata T
    Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination.
    Holmgren J; Svennerholm AM; Gothefors L; Jertborn M; Stoll B
    Infect Immun; 1988 Jan; 56(1):230-3. PubMed ID: 3275584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).
    Cheng E; Cárdenas-Freytag L; Clements JD
    Vaccine; 1999 Aug; 18(1-2):38-49. PubMed ID: 10501233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
    de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
    Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb.
    Fukuta S; Magnani JL; Twiddy EM; Holmes RK; Ginsburg V
    Infect Immun; 1988 Jul; 56(7):1748-53. PubMed ID: 3290106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.